Extendicare Inc. · TSX:EXE

Extendicare — Q4 2020 Earnings Presentation

20 slides from Extendicare's earnings presentation, Feb 26, 2021

  1. Slide 1: 2020 Fourth Quarter & Year End Results Conference Call

    DELIVERING BEST-IN-CLASS SERVICES & GROWING LONG-TERM VALUE 2020 Fourth Quarter & Year End Results Conference Call February 26, 2021 NON-GAAP MEASURES “EBITDA”, “Adjusted EBITDA”, “net operating income” (NOI), “funds from operations” (FFO), and “adjusted funds from operations” (AFFO) are non-GAAP me

  2. Slide 2: Forward-Looking Statements

    FORWARD-LOOKING STATEMENTS This presentation contains certain forward-looking statements within the meaning of applicable Canadian securities laws (“forward-looking statements” or “forward-looking information”). Statements other than statements of historical fact contained in this presentation may b

  3. Slide 3: COVID-19 Update

    COVID-19 UPDATE  Safety of our residents, clients and staff remains our top priority  Vaccine rollout under way:  91% of LTC residents vaccinated with first dose and 65% have received second dose  71% of Esprit residents vaccinated with first dose  33% of LTC and Esprit staff have first dose 

  4. Slide 4: 2020 Fourth Quarter Highlights

    2020 FOURTH QUARTER HIGHLIGHTS  Impact of COVID-19:  Pandemic costs exceeded funding by $10.3M ($30.1M FY20)  Lower occupancy in LTC and retirement living  Home health care volumes recovering in the face of workforce capacity constraints  ParaMed received $40.4M under the Canada Emergency Wage

  5. Slide 5: Long-Term Care – Redevelopment Advancing

    LONG-TERM CARE – REDEVELOPMENT ADVANCING  Long-term plan to replace aging infrastructure is advancing successfully  Sudbury 256-bed LTC home under construction:  Greenfield, commenced November 2020 with completion anticipated in Q4 2022  Estimated investment of $62.3M  Replacing existing 234-be

  6. Slide 6: Long-Term Care – COVID-19 Drives Increased Costs, Lower Occupancy

    LONG-TERM CARE – COVID-19 DRIVES INCREASED COSTS, LOWER OCCUPANCY  COVID-19 costs exceed funding support by $8.7M in Q4 2020 and $24.2M in 2020 (1)  Occupancy declines due to COVID-19 admissions restrictions supported by basic Average Occupancy occupancy funding protection 100% 90%  Recent COVID

  7. Slide 7: ParaMed – Volume Recovering, Limited by Staffing Capacity

    PARAMED – VOLUME RECOVERING, LIMITED BY STAFFING CAPACITY  Home care referrals recovered to pre-COVID levels  ADV steadily recovering from COVID lows but constrained by workforce capacity:  Q4 ADV up 5.2% from Q3 2020  4-weeks ending February 14, 2021 up 1.6% from Q4 Home Health Care Average Dai

  8. Slide 8: Financial Review

    FINANCIAL REVIEW 2020 Fourth Quarter & Year End Results 8

  9. Slide 9: Consolidated Results

    CONSOLIDATED RESULTS Three and twelve months ended December 31, 2020 ($ millions, except per share amounts) Revenue Revenue (1) Q4 Q4 YTD YTD Q4 Q4 YTD YTD 2020 2019 Change 2020 2019 Change 2020 2019 Change 2020 2019 Change $307.7 $290.9 5.8% $1,158.3 $1,132.0 2.3% $307.7 $277.6 10.9% $1,155.3 $1,07

  10. Slide 10: Long-Term Care

    LONG-TERM CARE Three and twelve months ended December 31, 2020  Q4 revenue up $25.5M, includes COVID-19 funding of $25.6M Revenue  Q4 NOI impacted by: Q4 2020 $192.1M 15.3%  Costs in excess of COVID-19 funding of $8.7M (full year $24.2M) YTD 2020 $715.6M 11.1%  Lower preferred occupancy revenue

  11. Slide 11: Home Health Care

    HOME HEALTH CARE Three and twelve months ended December 31, 2020  Q4 revenue(1) increased slightly as Revenue (1) COVID-19 and pandemic pay funding Q4 2020 $96.4M 3.2% were largely offset by lower average YTD 2020 $365.2M -1.3% daily volumes (ADVs) NOI (1)  Q4 NOI(1) impacted by decline in ADV vs

  12. Slide 12: Retirement Living

    RETIREMENT LIVING Three and twelve months ended December 31, 2020  Q4 revenue up 6.1% and NOI up 11.0% Revenue  Contributions from lease-up and non same- Q4 2020 $12.0M 6.1% store communities offset the negative impact of COVID-19 on occupancy and cost levels YTD 2020 $47.8M 15.8% NOI  Q4 stabili

  13. Slide 13: Other Canadian Operations

    OTHER CANADIAN OPERATIONS Three and twelve months ended December 31, 2020 Revenue  Q4 revenue up 16.4% and NOI up Q4 2020 $7.2M 16.4% 32.2% YTD 2020 $26.8M 12.0%  Growth in SGP client base of 21.9% NOI and lower travel and marketing Q4 2020 $4.6M 32.2% costs due to COVID restrictions margin 63.2%

  14. Slide 14: Strong Financial Position

    STRONG FINANCIAL POSITION As at December 31, 2020 Long-term EBITDA interest Debt to Weighted Debt (1) Cash coverage GBV average rate $580M $180M Q4 2020 4.7x 45.9% 4.3% Q3 2020 4.0X 47.9% 4.4% Q4 2019 3.1X 49.0% 4.7% Debt Maturities ($ millions) Construction(2) Lease Liabilities Mortgage Amortizatio

  15. Slide 15: Compelling Growth Opportunities Across the Care Continuum

    COMPELLING GROWTH OPPORTUNITIES ACROSS THE CARE CONTINUUM B2C: direct services to seniors LONG-TERM CARE HOME HEALTH CARE RETIREMENT LIVING 58 8.4M 11 Long-term care Home health care Retirement communities homes owned hours delivered (TTM) owned B2B: contract & consulting services GROUP PURCHASING C

  16. Slide 16: Thank You

    THANK YOU

  17. Slide 17: Appendix

    EXTENDICARE® APPENDIX ... helping people live better

  18. Slide 18: 2020 Estimated COVID-19 Revenue, Operating Expenses and Administrative Costs

    2020 ESTIMATED COVID-19 REVENUE, OPERATING EXPENSES AND ADMINISTRATIVE COSTS Three and twelve months ended December 31, 2020 and 2019 ($ millions) Q4 2020 YTD 2020 Retirement Home Health Retirement Home Health LTC Total LTC Total Living Care Living Care Revenue $25.6 - $6.4 $32.0 $64.7 - $23.6 $88.3

  19. Slide 19: ParaMed Factors Impacting Comparability

    PARAMED FACTORS IMPACTING COMPARABILITY Three and twelve months ended December 31, 2020 and 2019 ♦ ParaMed B.C. contracts (exited in January 2020) ♦ ParaMed Bill 148 (retro funding of $2.2M recorded in Q2 2019) ♦ ParaMed CEWS ($91.2M received in 2020 ($40.4M in Q4 2020)) NET IMPACT Q4 Q4 YTD YTD ($

  20. Slide 20: Results – NOI by Division

    RESULTS – NOI BY DIVISION (1) Three and twelve months ended December 31, 2020 ($ millions) Long-term Care NOI and Margin (1) Home Health Care NOI and Margin (1) Q4 Q4 YTD YTD Q4 Q4 YTD YTD 2020 2019 Change 2020 2019 Change 2020 2019 Change 2020 2019 Change $17.9 $19.1 -6.2% $76.0 $76.3 -0.5% $5.2 $5

Extendicare — Q4 2020 Earnings Presentation on 6ix